O
BRKR icon

OrbiMed’s Bruker BRKR Stock Holding History

OrbiMed’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-555,789
Closed -$26.2M – 114
2025
Q4 		$26.2M Buy
+555,789
New +$23.5M 0.53% 53

Other funds holding BRKR

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed's BRKR Position: Q1 2026 in Review

OrbiMed sold out of Bruker (BRKR) in Q1 2026, closing a stake of 555,789 shares — an estimated $26.2M sold.

OrbiMed first reported a position in BRKR in Q4 2025 and held it in 1 quarter. The position peaked at $26.2M in Q4 2025. 345 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.

  • OrbiMed reported no remaining Bruker position as of Q1 2026 after selling out during the quarter.
  • OrbiMed sold 555,789 Bruker shares in Q1 2026, an estimated $26.2M.
  • OrbiMed first reported a position in Bruker in Q4 2025 and held it in 1 quarter.
  • OrbiMed's Bruker position peaked at $26.2M in Q4 2025.
  • 345 funds tracked by Wall St. Rank held Bruker as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.